Hengliang Hou

机构：Guangdong Academy of Medical Sciences, Southern Medical University, South China University of Technology

发表论文 8 篇 · 总被引 44 次 · h-index 3

代表论文

• A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy (2023 · Bioactive Materials · 被引 29)
• Anti-Triggering Receptor Expressed on Myeloid Cells 2-Conjugated Nanovesicles Loaded Vadimezan Reprogram Tumor-Associated Macrophages to Combat Recurrent Lung Cancer (2025 · ACS Nano · 被引 5)
• An all-in-one polymeric nanomedicine as in situ cascade cancer vaccine for potent cancer immunotherapy (2025 · Nano Today · 被引 4)
• NIR-II light-driven in situ nanovaccine for cancer immunotherapy via lymph node migration-mediated accumulation (2025 · Theranostics · 被引 3)
• Capturing Hydrophilic Chemotherapeutics Agents Into siRNA‐Encapsulated Vesicle‐Like Nanoparticles for Convenient ICB‐Chemo Combination Therapy (2024 · Small · 被引 3)
• Effect of NIR-II on cancer nanocomposite vaccines for lymph node targeted delivery and enhanced immunotherapy. (2024 · Journal of Clinical Oncology)